Prevalence of Amyloid PET Positivity in Dementia Syndromes
Author(s) -
Rik Ossenkoppele,
Willemijn J. Jansen,
Gil D. Rabinovici,
Dirk L. Knol,
Wiesje M. van der Flier,
Bart N.M. van Berckel,
Philip Scheltens,
Pieter Jelle Visser,
Sander C.J. Verfaillie,
Marissa D. Zwan,
Sofie M. Adriaanse,
Adriaan A. Lammertsma,
Frederik Barkhof,
William J. Jagust,
Bruce L. Miller,
Howard J. Rosen,
Susan Landau,
Victor L. Villemagne,
Christopher C. Rowe,
Dong Yeob Lee,
Duk L. Na,
Sang Won Seo,
Marie Sarazin,
Catherine M. Roe,
Osama Sabri,
Henryk Barthel,
Norman Koglin,
John R. Hodges,
Cristian E. Leyton,
Rik Vandenberghe,
Koen Van Laere,
Alexander Drzezga,
Stefan Förster,
Timo Grimmer,
Pascual SánchezJuan,
J.M. Carril,
Vincent Mok,
Vincent Camus,
William E. Klunk,
Ann D. Cohen,
Philipp T. Meyer,
Sabine Hellwig,
Andrew B. Newberg,
Kristian Steen Frederiksen,
Adam Fleisher,
Mark A. Mintun,
David A. Wolk,
Agneta Nordberg,
Juha O. Rinne,
Gaël Chételat,
Alberto Lleó,
Rafael Blesa,
Juan Fortea,
Karine Madsen,
Karen M. Rodrigue,
David J. Brooks
Publication year - 2015
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2015.4669
Subject(s) - medicine , dementia , apolipoprotein e , amyloid (mycology) , positron emission tomography , alzheimer's disease , pathology , disease , nuclear medicine
Amyloid-β positron emission tomography (PET) imaging allows in vivo detection of fibrillar plaques, a core neuropathological feature of Alzheimer disease (AD). Its diagnostic utility is still unclear because amyloid plaques also occur in patients with non-AD dementia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom